ARGX stock profile
Argen X SE Company Profile
Argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer.
Company information
- Company Name Argen X SE
- Industry Biological Product (except Diagnostic) Manufacturing
- CEO Tim Van Hauwermeiren
- Security Name Argen X SE - ADR
- Sector Manufacturing
- Employees 336
- Exchange NASDAQ
- Country Netherlands
- State Noord Brabant
- City Breda
- Address Willemstraat 5
- Phone 31763030488
- Website https://www.argenx.com/
- Zip 4811 AH
Peers
- OVAT-CA
- OVID
- OVIT
- OYST
Top Executives
- Entity Name
- Position
- Report Date
Related News
Exxon Mobil (NYSE:XOM): Unveiling Its $105 Value Opportunity
TradingNEWS Archive
08.01.25
Qualcomm’s $150 Valuation: A Balanced Play of Growth and Risks
TradingNEWS Archive
08.01.25
Super Micro Computer (NASDAQ:SMCI): Navigating Risks to Reach $100
TradingNEWS Archive
08.01.25
Interactive Brokers (NYSE:IBKR): Positioned for Growth with $210–$270 Price Target
TradingNEWS Archive
07.01.25
How does Petrobras (NYSE:PBR) maintain high dividends and low production costs despite Brazil's economic challenges?
TradingNEWS Archive
07.01.25
What makes NVIDIA (NASDAQ:NVDA) a compelling buy at $144 per share in 2025?
TradingNEWS Archive
07.01.25